Trials / Conditions / Pilocytic Astrocytoma

Pilocytic Astrocytoma

10 registered clinical trials studyying Pilocytic Astrocytoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Cl NCT06915649	University Hospital, Montpellier	—
Suspended	Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumo NCT05934630	Pediatric Brain Tumor Consortium	—
Terminated	Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors NCT07121829	Day One Biopharmaceuticals, Inc.	Phase 1
Terminated	Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors NCT04985604	Day One Biopharmaceuticals, Inc.	Phase 2
Recruiting	Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms NCT04541082	Jazz Pharmaceuticals	Phase 1
Active Not Recruiting	Pediatric Long-Term Follow-up and Rollover Study NCT03975829	Novartis Pharmaceuticals	Phase 4
Recruiting	Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma NCT04065776	St. Jude Children's Research Hospital	N/A
Completed	Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 NCT02684058	Novartis Pharmaceuticals	Phase 2
Terminated	Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance De NCT02372409	Washington University School of Medicine	Phase 2
Completed	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas NCT01837862	Julie Krystal	Phase 1 / Phase 2